PAK4 and Patent ductus arteriosus: The fact that both PAK1 and PAK4 have been implicated in intra-tumoral T-cell response, suggested that PAK1 and PAK4 inhibition may function synergistically in suppressing the growth of PDA [10, 16, 31].